DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Peeters M. et al.
Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.
J Clin Oncol 2010;
28: 4706-1713
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.